Form EFFECT Whitehawk Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 9, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Animal Capital Closes $33 Million Fund III to Double Down on Early-Stage Strategy
- Med-Metrix Enters Into Definitive Agreement to Acquire CanAide to Enhance Patient Access and Revenue Cycle Performance
- FRANK J. RUSSO OFFICIALLY QUALIFIES FOR FLORIDA GOVERNOR BALLOT, LAUNCHES NEXT PHASE OF STATEWIDE CAMPAIGN
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
